CDB-4124

	WikiDoc Resources for CDB-4124
Articles
Most recent articles on CDB-4124 Most cited articles on CDB-4124 Review articles on CDB-4124 Articles on CDB-4124 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on CDB-4124 Images of CDB-4124 Photos of CDB-4124 Podcasts & MP3s on CDB-4124 Videos on CDB-4124
Evidence Based Medicine
Cochrane Collaboration on CDB-4124 Bandolier on CDB-4124 TRIP on CDB-4124
Clinical Trials
Ongoing Trials on CDB-4124 at Clinical Trials.gov Trial results on CDB-4124 Clinical Trials on CDB-4124 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on CDB-4124 NICE Guidance on CDB-4124 NHS PRODIGY Guidance FDA on CDB-4124 CDC on CDB-4124
Books
Books on CDB-4124
News
CDB-4124 in the news Be alerted to news on CDB-4124 News trends on CDB-4124
Commentary
Blogs on CDB-4124
Definitions
Definitions of CDB-4124
Patient Resources / Community
Patient resources on CDB-4124 Discussion groups on CDB-4124 Patient Handouts on CDB-4124 Directions to Hospitals Treating CDB-4124 Risk calculators and risk factors for CDB-4124
Healthcare Provider Resources
Symptoms of CDB-4124 Causes & Risk Factors for CDB-4124 Diagnostic studies for CDB-4124 Treatment of CDB-4124
Continuing Medical Education (CME)
CME Programs on CDB-4124
International
CDB-4124 en Espanol CDB-4124 en Francais
Business
CDB-4124 in the Marketplace Patents on CDB-4124
Experimental / Informatics
List of terms related to CDB-4124

CDB-4124

IUPAC name	17α-acetoxy-21-methoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione)
Identifiers
CAS number	136960-00-4
MeSH	CDB-4124
Properties
Molecular formula	C₃₁H₃₉NO₅
Molar mass	505.65
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references

CDB-4124 (Proellex™, Progenta™) is a selective progesterone receptor modulator.^[1]

References

↑ Attardi BJ, Burgenson J, Hild SA, Reel JR (2004). "In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone". J Steroid Biochem Mol Biol 88 (3): 277-88. doi:10.1016/j.jsbmb.2003.12.004. PMID 15120421.

v • d • e Sex hormones and related agents (primarily G03, also L02, H01C) - human endogenous in CAPS
Progestogens: (receptor)	PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, Tibolone Selective progesterone receptor modulator: Asoprisnil, CDB-4124 Antiprogestogen: Mifepristone
Androgens: (receptor)	TESTOSTERONE, Androstanolone, Fluoxymesterone, Mesterolone, Methyltestosterone, (see also anabolic steroids) Antiandrogens: Bicalutamide, Cyproterone, Dienogest, Flutamide, Nilutamide, Spironolactone
Estrogens: (receptor)	ESTRADIOL, ESTRIOL, ESTRONE, Chlorotrianisene, Dienestrol, Diethylstilbestrol, Ethinylestradiol, Fosfestrol, Mestranol, Polyestradiol phosphate Selective estrogen receptor modulator: Afimoxifene, Arzoxifene, Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, Toremifene Aromatase inhibitor: Aminogluthetimide, Anastrozole, Atamestane, Exemestane, Formestane, Letrozole, Vorozole
Gonadotropins: (FSHR/LHCGR)	ovulation stim.: Clomifene, Urofollitropin Antigonadotropins: Danazol, Gestrinone
GnRH: (receptor)	agonist: Buserelin, Goserelin, Histrelin, Leuprorelin, Nafarelin, Triptorelin antagonist: Abarelix, Cetrorelix, Ganirelix

Articles
WikiDoc Resources for CDB-4124
Most recent articles on CDB-4124 Most cited articles on CDB-4124 Review articles on CDB-4124 Articles on CDB-4124 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on CDB-4124 Images of CDB-4124 Photos of CDB-4124 Podcasts & MP3s on CDB-4124 Videos on CDB-4124
Evidence Based Medicine
Cochrane Collaboration on CDB-4124 Bandolier on CDB-4124 TRIP on CDB-4124
Clinical Trials
Ongoing Trials on CDB-4124 at Clinical Trials.gov Trial results on CDB-4124 Clinical Trials on CDB-4124 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on CDB-4124 NICE Guidance on CDB-4124 NHS PRODIGY Guidance FDA on CDB-4124 CDC on CDB-4124
Books
Books on CDB-4124
News
CDB-4124 in the news Be alerted to news on CDB-4124 News trends on CDB-4124
Commentary
Blogs on CDB-4124
Definitions
Definitions of CDB-4124
Patient Resources / Community
Patient resources on CDB-4124 Discussion groups on CDB-4124 Patient Handouts on CDB-4124 Directions to Hospitals Treating CDB-4124 Risk calculators and risk factors for CDB-4124
Healthcare Provider Resources
Symptoms of CDB-4124 Causes & Risk Factors for CDB-4124 Diagnostic studies for CDB-4124 Treatment of CDB-4124
Continuing Medical Education (CME)
CME Programs on CDB-4124
International
CDB-4124 en Espanol CDB-4124 en Francais
Business
CDB-4124 in the Marketplace Patents on CDB-4124
Experimental / Informatics
List of terms related to CDB-4124